Crossmark

Characteristics of patients with schizophrenia switching from oral antipsychotics to once-monthly paliperidone palmitate (PP1M): a systematic review

Published Online: 2024-01-19

Authors

Li, Qian

Li, Xin

Ye, Chong

Jia, Miaomiao

Si, Tianmei http://orcid.org/0000-0001-9823-2720
Funding

Funding for this research was provided by:

Xi’an Janssen Pharmaceutical Ltd
License Information

Text and Data Mining valid from 2024-01-19

Version of Record valid from 2024-01-19
More Information

Article History

Received: 9 August 2023

Accepted: 9 January 2024

First Online: 19 January 2024

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current